We are live on ! Find out more
ABVX

Abivax

38 hedge funds and large institutions have $372M invested in Abivax in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

11% more capital invested

Capital invested by funds: $334M → $372M (+$37.5M)

7.5% more ownership

Funds ownership: 37.15%44.65% (+7.5%)

6% more funds holding

Funds holding: 3638 (+2)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

Holders
38
Holders Change
+2
Holders Change %
+5.56%
% of All Funds
0.55%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
4
Increased
12
Reduced
14
Closed
2
Calls
Puts
Net Calls
Net Calls Change

ABVX Hedge Fund Activity: Q2 2024 in Review

38 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Abivax (ABVX) for Q2 2024, worth a combined $372M — up 11% from $334M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ABVX positions and 2 closed out — a net gain of 2 holders — while 12 added to existing stakes and 14 trimmed.

The largest buyer was TCG Crossover Management, adding an estimated $70.9M. The largest seller was Commodore Capital, cutting an estimated $8.74M.

  • 38 institutional investors held Abivax (ABVX) as of Q2 2024, up from 36 in Q1 2024.
  • Funds reported $372M of Abivax stock for Q2 2024, up 11% quarter-over-quarter.
  • 4 funds opened new Abivax positions in Q2 2024 and 2 closed out, a net change of +2 holders.
  • The largest Abivax buyer in Q2 2024 was TCG Crossover Management, an estimated $70.9M added.
  • The largest Abivax seller in Q2 2024 was Commodore Capital, an estimated $8.74M sold.

Based on aggregated 13F filings for Q2 2024.